Quest Diagnostics SG&A Expenses 2010-2024 | DGX

Quest Diagnostics annual/quarterly sg&a expenses history and growth rate from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
  • Quest Diagnostics sg&a expenses for the quarter ending September 30, 2024 were $0.448B, a 17.89% increase year-over-year.
  • Quest Diagnostics sg&a expenses for the twelve months ending September 30, 2024 were $1.711B, a 4.84% decline year-over-year.
  • Quest Diagnostics annual sg&a expenses for 2023 were $1.642B, a 12.38% decline from 2022.
  • Quest Diagnostics annual sg&a expenses for 2022 were $1.874B, a 8.51% increase from 2021.
  • Quest Diagnostics annual sg&a expenses for 2021 were $1.727B, a 11.42% increase from 2020.
Quest Diagnostics Annual SG&A Expenses
(Millions of US $)
2023 $1,642
2022 $1,874
2021 $1,727
2020 $1,550
2019 $1,457
2018 $1,424
2017 $1,443
2016 $1,380
2015 $1,679
2014 $1,728
2013 $1,704
2012 $1,745
2011 $1,743
2010 $1,659
2009 $1,748
Quest Diagnostics Quarterly SG&A Expenses
(Millions of US $)
2024-09-30 $448
2024-06-30 $416
2024-03-31 $440
2023-12-31 $407
2023-09-30 $380
2023-06-30 $416
2023-03-31 $439
2022-12-31 $563
2022-09-30 $464
2022-06-30 $422
2022-03-31 $425
2021-12-31 $464
2021-09-30 $427
2021-06-30 $429
2021-03-31 $407
2020-12-31 $447
2020-09-30 $396
2020-06-30 $360
2020-03-31 $347
2019-12-31 $349
2019-09-30 $362
2019-06-30 $362
2019-03-31 $384
2018-12-31 $356
2018-09-30 $354
2018-06-30 $351
2018-03-31 $363
2017-12-31 $382
2017-09-30 $348
2017-06-30 $358
2017-03-31 $355
2016-12-31 $99
2016-09-30 $409
2016-06-30 $430
2016-03-31 $442
2015-12-31 $429
2015-09-30 $402
2015-06-30 $429
2015-03-31 $419
2014-12-31 $427
2014-09-30 $446
2014-06-30 $440
2014-03-31 $415
2013-12-31 $415
2013-09-30 $423
2013-06-30 $418
2013-03-31 $448
2012-12-31 $421
2012-09-30 $417
2012-06-30 $424
2012-03-31 $483
2011-12-31 $386
2011-09-30 $447
2011-06-30 $463
2011-03-31 $448
2010-12-31 $382
2010-09-30 $427
2010-06-30 $419
2010-03-31 $431
2009-12-31 $433
2009-09-30 $442
2009-06-30 $449
2009-03-31 $424
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $16.912B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.704B 11.92
DaVita (DVA) United States $12.098B 15.65
Encompass Health (EHC) United States $9.453B 22.29
Chemed (CHE) United States $7.853B 24.14
Elanco Animal Health (ELAN) United States $5.843B 13.91
RadNet (RDNT) United States $5.284B 117.02
Option Care Health (OPCH) United States $3.848B 18.23
Amedisys (AMED) United States $2.744B 19.53
LifeStance Health (LFST) United States $2.698B 0.00
Addus HomeCare (ADUS) United States $2.350B 27.57
Astrana Health (ASTH) United States $1.974B 26.99
U.S Physical Therapy (USPH) United States $1.380B 36.27
Pennant (PNTG) United States $0.938B 37.92
Aveanna Healthcare Holdings (AVAH) United States $0.873B 0.00
Atai Life Sciences (ATAI) Germany $0.200B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00